• Spermine Tetrahydrochloride: Precision Control in Protoplast

  2026-07-10

  Explore the science of spermine tetrahydrochloride in membrane protection, protein crystallization, and advanced crosslinking, revealing evidence-driven assay design and practical insights not found in prior content.

• (-)-JQ1: Precision Control for BET Bromodomain Assays

  2026-07-09

  (-)-JQ1 offers researchers the gold-standard negative control for dissecting BET bromodomain function in epigenetics and cancer biology workflows. Its rigorous application ensures confident differentiation of on-target effects from off-target noise, directly supporting reproducibility and precision in BRD4-targeted studies.

• KPT330 Enhances CRISPR-Cas9 Specificity via mRNA Nuclear Exp

  2026-07-09

  The referenced study demonstrates that the FDA-approved drug KPT330, a selective inhibitor of nuclear export (SINE), can improve the precision of CRISPR-Cas9 genome and base editing by regulating Cas9 mRNA nuclear export. This discovery introduces a new, indirect approach to reducing off-target effects in genome engineering, offering practical avenues for safer and more accurate gene editing.

• Dietary Arachidonic Acid Enhances Vaccine-Induced Humoral Im

  2026-07-08

  A recent study demonstrates that dietary supplementation with arachidonic acid significantly accelerates and amplifies vaccine-induced neutralizing antibody production in both mice and humans. This mechanistic insight reveals arachidonic acid's role as a modulator of germinal center B cell responses, with implications for rapid immunization strategies.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-07-08

  Schwartz's dissertation advances the methodology for evaluating anti-cancer drug responses in vitro by distinguishing between proliferative arrest and cell death. These insights clarify how DNA methyltransferase inhibitors like SGI-1027 can be more accurately assessed for their dual effects, improving experimental reproducibility and translational relevance.

• Dual-Genome OXPHOS Disruption: LRPPRC Inhibition Plus Dasati

  2026-07-07

  The reference study reveals a novel strategy for cancer therapy by combining LRPPRC inhibition with Dasatinib, resulting in synergistic disruption of mitochondrial oxidative phosphorylation (OXPHOS) through coordinated nuclear and mitochondrial gene suppression. These findings offer mechanistic insights and a rationale for combination therapies in OXPHOS-dependent tumors.

• LY-411575: Gamma-Secretase Inhibitor for Advanced Research

  2026-07-07

  LY-411575 stands out as a benchmark gamma-secretase inhibitor, enabling precise modulation of amyloid beta and Notch signaling in Alzheimer’s and cancer research. This article breaks down its applied workflows, protocol parameters, and troubleshooting strategies for high-impact translational studies.

• Rucaparib (AG-014699): Precision Tools for DNA Repair Pathwa

  2026-07-06

  Explore how Rucaparib (AG-014699) enables unparalleled precision in dissecting DNA repair pathways and radiosensitization mechanisms in cancer biology research. This article delivers unique insight into assay design, transporter effects, and protocol optimization for advanced DNA damage response studies.

• CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta

  2026-07-06

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs via lipid nanoparticles efficiently edits the LGMN gene and reduces metastatic potential in breast cancer models. The research clarifies optimized in vitro transcription protocols for gRNA and Cas9 mRNA, offering insights for gene-editing approaches targeting tumor metastasis.

• Placental miR-519d-3p Exosomes Disrupt Immune Tolerance in P

  2026-07-05

  This study uncovers how placenta-derived exosomes enriched in miR-519d-3p promote immune cell dysregulation at the maternal-fetal interface, contributing to preeclampsia pathogenesis. It demonstrates mechanistic links between exosomal miRNA signaling, T cell fate, and immune tolerance failure.

• Tyrothricin: Advanced Mechanisms and Emerging Research Horiz

  2026-07-04

  Explore Tyrothricin as a peptide antibiotic mixture with unique membrane-disrupting mechanisms. This in-depth article unveils advanced insights for antimicrobial research, integrating new perspectives on cellular iron homeostasis and practical assay design.

• Nanozyme-Functionalized Hydrogels Disrupt IDD’s ROS-Ferropto

  2026-07-03

  This study introduces a nanozyme-functionalized hydrogel capable of breaking the self-propagating cycle of ROS, ferroptosis, and inflammation in intervertebral disc degeneration (IDD). By leveraging a nucleus pulposus cell membrane-coated black phosphorus–cerium oxide nanozyme, the approach achieves durable antioxidant effects and suppression of pro-inflammatory signaling, offering a new paradigm for structural and functional disc repair.

• Rapid In Vivo and Cell-Based Screening in Pancreatic Cancer

  2026-07-03

  This study introduces a rapid, dual in vitro and in vivo screening platform leveraging Rgs16::GFP expression to evaluate chemotherapeutic combinations in pancreatic ductal adenocarcinoma (PDA). The approach enables efficient identification of drug synergies targeting early-stage lesions, with implications for accelerating preclinical development in cancer biology research.

• EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Genome Editing Precision

  2026-07-02

  EZ Cap™ Cas9 mRNA (m1Ψ) from APExBIO stands apart for its Cap1 structure and m1Ψ modification, enabling highly efficient, immune-evasive genome editing in mammalian cells. This guide details optimized workflows, troubleshooting insights, and the latest evidence on mRNA nuclear export control for superior CRISPR-Cas9 specificity.

• Translating Norepinephrine Bitartrate: From Mechanism to Mod

  2026-07-02

  This thought-leadership article provides translational researchers with a mechanistic, evidence-based, and strategically actionable framework for leveraging (-)-Norepinephrine (+)-bitartrate in cardiovascular and cardiomyopathy studies. It contextualizes recent clinical dosing insights, benchmarks competitive products, and delivers practical protocol guidance that bridges in vitro research with clinical realities.

552 records 12/37 page Previous Next First page 上5页 1112131415 下5页 Last page